EPIQ Inspira Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound System
Philips Ultrasound, LLC · Decision date Sep 25, 2026
What did the FDA decide?
FDA recorded a substantial equivalence (SESE) decision for K262548 on September 25, 2026, covering the EPIQ Inspira Series and Affiniti Series Diagnostic Ultrasound Systems from Philips Ultrasound, LLC. The submission, dated and received July 23, 2026, is a Traditional 510(k) under 21 CFR 892.1550 (Class II, product code IYN), with secondary classifications including 892.1560, 892.1570, 892.2050 and 870.1200. Clearance is not PMA approval.
The recorded change introduces 2D Auto LA, an automated left atrial quantification feature, on both systems, and adds the EPIQ Inspira Series as a variant within the EPIQ family. The summary describes automated endocardial border detection, speckle-tracking strain analysis, biplane volume calculation and user contour editing, with the user responsible for accepting, editing or rejecting outputs. Listed predicates are K253595 (primary) and K190913 (secondary). The source does not include the decision letter's basis, performance-test data or the full indications text for the Affiniti system.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262548
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Philips Ultrasound, LLC
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Applicant
- Philips Ultrasound, LLC
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K262548 received
Application receipt date recorded by FDA.
K262548 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Philips Ultrasound, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Bothell, WA
Sources and methodology
- Original FDA record: K262548
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

